Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.13 USD
-1.53%
Market Closed
Updated:
Apr 25, 2024
Section:
Relative Value
The Relative Value of one
PBH
stock under the Base Case scenario is
81.18
USD.
Compared to the current market price of 70.13 USD,
Prestige Consumer Healthcare Inc
is
Undervalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PBH
Relative Value
Base Case
81.18
USD
Undervaluation 14%
Valuation Multiples
Multiples Across Competitors
PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors
Prestige Consumer Healthcare Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
3.5B USD | 3.1 | -43.2 | 463 | -222.9 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
695.1B USD | 20.4 | 132.6 | 59.9 | 68.8 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
3.9T DKK | 16.9 | 46.8 | 34.2 | 37.3 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | |
| JP |
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
82T JPY | 255.8 | 9 733.7 | 1 771.8 | 4 320.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
357.5B USD | 4.4 | 8.8 | 11.8 | 15.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
321.5B USD | 5.3 | 880.9 | 43.9 | 85.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
176B GBP | 4.8 | 36.8 | 139.6 | 223.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182.2B CHF | 4.3 | 13.4 | 9.8 | 16.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
177.1B CHF | 3 | 15.4 | 8.5 | 10 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
